Skip to main content
Top
Published in: American Journal of Clinical Dermatology 5/2003

01-05-2003 | Therapy In Practice

Cutaneous Manifestations of Endocrine Disorders

A Guide for Dermatologists

Author: Dr Serge A. Jabbour

Published in: American Journal of Clinical Dermatology | Issue 5/2003

Login to get access

Abstract

Thyrotoxicosis may lead to multiple cutaneous manifestations, including hair loss, pretibial myxedema, onycholysis and acropachy. In patients with hypothyroidism, there is hair loss, the skin is cold and pale, with myxedematous changes, mainly in the hands and in the periorbital region.
The striking features of Cushing syndrome are centripetal obesity, moon facies, buffalo hump, supraclavicular fat pads, and abdominal striae. In Addison disease, the skin is hyperpigmented, mostly on the face, neck and back of the hands.
Virtually all patients with acromegaly have acral and soft tissue overgrowth, with characteristic findings, like macrognathia and enlarged hands and feet. The skin is thickened, and facial features are coarser.
Conditions leading to hyperandrogenism in females present as acne, hirsutism and signs of virilization (temporal balding, clitoromegaly).
A prominent feature of hypopituitarism is a pallor of the skin with a yellowish tinge. The skin is also thinner, resulting in fine wrinkling around the eyes and mouth, making the patient look older.
Primary hyperparathyroidism is rarely associated with pruritus and chronic urticaria. In hypoparathyroidism, the skin is dry, scaly and puffy. Nails become brittle and hair is coarse and sparse. Pseudohypoparathyroidism may have a special somatic phenotype known as Albright osteodystrophy. This consists of short stature, short neck, brachydactyly and subcutaneous calcifications.
Some of the cutaneous manifestations of diabetes mellitus include necrobiosis lipoidica diabeticorum, diabetic dermopathy, scleredema adultorum and acanthosis nigricans.
Literature
1.
go back to reference Brownlie BE, Wells JE. The epidemiology of thyrotoxicosis in New Zealand: incidence and geographical distribution in North Canterbury, 1983–1985. Clin Endocrinol 1990; 33 (2): 249–259CrossRef Brownlie BE, Wells JE. The epidemiology of thyrotoxicosis in New Zealand: incidence and geographical distribution in North Canterbury, 1983–1985. Clin Endocrinol 1990; 33 (2): 249–259CrossRef
2.
go back to reference Reinwein D, Benker G, Konig MP, et al. The different types of hyperthyroidism in Europe: results of a prospective study of 924 patients. J Endocrinol Invest 1988; 11 (3): 193–200PubMed Reinwein D, Benker G, Konig MP, et al. The different types of hyperthyroidism in Europe: results of a prospective study of 924 patients. J Endocrinol Invest 1988; 11 (3): 193–200PubMed
3.
go back to reference Williams I, Ankrett VO, Lazarus JH, et al. Aetiology of hyperthyroidism in Canada and Wales. J Epidemiol Community Health 1983; 37 (3): 245–248PubMedCrossRef Williams I, Ankrett VO, Lazarus JH, et al. Aetiology of hyperthyroidism in Canada and Wales. J Epidemiol Community Health 1983; 37 (3): 245–248PubMedCrossRef
4.
go back to reference Dabon-Almirante CLM, Surks MI. Clinical and laboratory diagnosis of thyrotoxicosis. Endocrinol Metab Clin North Am 1998; 27 (1): 25–35PubMedCrossRef Dabon-Almirante CLM, Surks MI. Clinical and laboratory diagnosis of thyrotoxicosis. Endocrinol Metab Clin North Am 1998; 27 (1): 25–35PubMedCrossRef
5.
go back to reference Mullin GE, Eastern JS. Cutaneous signs of thyroid disease. Am Fam Physician 1986; 34 (4): 93–98PubMed Mullin GE, Eastern JS. Cutaneous signs of thyroid disease. Am Fam Physician 1986; 34 (4): 93–98PubMed
6.
7.
go back to reference Rosen T, Kleman GA. Thyroid and the skin. In: Callen JP, Jorizzo JL Greer KE, et al., editors. Dermatologic signs of internal disease. 2nd ed. Philadelphia: WB Saunders, 1995: 189 Rosen T, Kleman GA. Thyroid and the skin. In: Callen JP, Jorizzo JL Greer KE, et al., editors. Dermatologic signs of internal disease. 2nd ed. Philadelphia: WB Saunders, 1995: 189
8.
9.
go back to reference Freinkel RK. Cutaneous manifestations of endocrine diseases. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al., editors. Dermatology in general medicine. 4th ed. New York: McGraw-Hill, 1993: 2113–2131 Freinkel RK. Cutaneous manifestations of endocrine diseases. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al., editors. Dermatology in general medicine. 4th ed. New York: McGraw-Hill, 1993: 2113–2131
11.
go back to reference Rook A, Dawber R. Diseases of the hair and scalp. 2nd ed. Oxford: Blackwell Scientific Publications, 1991: 147 Rook A, Dawber R. Diseases of the hair and scalp. 2nd ed. Oxford: Blackwell Scientific Publications, 1991: 147
12.
go back to reference Norton LA. Disorders of the nails. In: Moschella SL, Hurley HJ, editors. Dermatology. 3rd ed. Philadelphia: WB Saunders, 1992: 1574 Norton LA. Disorders of the nails. In: Moschella SL, Hurley HJ, editors. Dermatology. 3rd ed. Philadelphia: WB Saunders, 1992: 1574
13.
go back to reference Locke W. Unusual manifestations of Graves’ disease. Med Clin North Am 1967; 51 (4): 915–924PubMed Locke W. Unusual manifestations of Graves’ disease. Med Clin North Am 1967; 51 (4): 915–924PubMed
14.
go back to reference Mullin GE, Eastern JS. Cutaneous consequences of accelerated thyroid function. Cutis 1986; 37: 109–114PubMed Mullin GE, Eastern JS. Cutaneous consequences of accelerated thyroid function. Cutis 1986; 37: 109–114PubMed
15.
go back to reference Davis PJ, Davis FB. Hyperthyroidism in patients over the age of 60 years. Medicine 1974; 53 (3): 161–181PubMedCrossRef Davis PJ, Davis FB. Hyperthyroidism in patients over the age of 60 years. Medicine 1974; 53 (3): 161–181PubMedCrossRef
16.
go back to reference Heymann WR. The skin in thyrotoxicosis. In: Braverman LE, Utiger RD, editors. The thyroid. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2000: 593–595 Heymann WR. The skin in thyrotoxicosis. In: Braverman LE, Utiger RD, editors. The thyroid. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2000: 593–595
17.
go back to reference Ortonne J-P, Mosher DB, Fitzpatrick TB. Vitiligo and other hypomelanoses of hair and skin. New York: Plenum, 1983: 182CrossRef Ortonne J-P, Mosher DB, Fitzpatrick TB. Vitiligo and other hypomelanoses of hair and skin. New York: Plenum, 1983: 182CrossRef
18.
go back to reference Cunliffe WJ, Hall R, Newell DJ, et al. Vitiligo, thyroid disease and autoimmunity. Br J Dermatol 1968; 80: 135–139PubMedCrossRef Cunliffe WJ, Hall R, Newell DJ, et al. Vitiligo, thyroid disease and autoimmunity. Br J Dermatol 1968; 80: 135–139PubMedCrossRef
19.
go back to reference Shong YK, Kim JA. Vitiligo in autoimmune thyroid disease. Thyroidology 1991; 3: 89–91PubMed Shong YK, Kim JA. Vitiligo in autoimmune thyroid disease. Thyroidology 1991; 3: 89–91PubMed
20.
go back to reference Kantor GR, Bernhard JD. Investigation of the pruritic patient in daily practice. Semin Dermatol 1995; 14: 290–296PubMedCrossRef Kantor GR, Bernhard JD. Investigation of the pruritic patient in daily practice. Semin Dermatol 1995; 14: 290–296PubMedCrossRef
21.
22.
go back to reference Collet E, Petit J-M, LaCroix M, et al. Chronic urticaria and thyroid auto-immunity. Ann Dermatol Venereol 1995; 122 (6–7): 413–416PubMed Collet E, Petit J-M, LaCroix M, et al. Chronic urticaria and thyroid auto-immunity. Ann Dermatol Venereol 1995; 122 (6–7): 413–416PubMed
23.
go back to reference Pegum JS, Grice K. Unusual skin eruptions with eosinophilia associated with hyperthyroidism. Br J Dermatol 1973; 88 (3): 295–301PubMedCrossRef Pegum JS, Grice K. Unusual skin eruptions with eosinophilia associated with hyperthyroidism. Br J Dermatol 1973; 88 (3): 295–301PubMedCrossRef
24.
go back to reference Thomson JA. Xanthelasma associated with thyrotoxicosis. J Clin Endocrinol Metab 1965 (Pt 1); 25: 758–760CrossRef Thomson JA. Xanthelasma associated with thyrotoxicosis. J Clin Endocrinol Metab 1965 (Pt 1); 25: 758–760CrossRef
25.
go back to reference Fatourechi V, Pajouhi M, Fransway AF. Dermopathy of Graves’ disease (pretibial myxedema): review of 150 cases. Medicine 1994; 73 (1): 1–7PubMedCrossRef Fatourechi V, Pajouhi M, Fransway AF. Dermopathy of Graves’ disease (pretibial myxedema): review of 150 cases. Medicine 1994; 73 (1): 1–7PubMedCrossRef
26.
go back to reference Horiuchi Y. Pretibial myxedema associated with chronic thyroiditis [letter]. Arch Dermatol 1985; 121 (4): 451PubMedCrossRef Horiuchi Y. Pretibial myxedema associated with chronic thyroiditis [letter]. Arch Dermatol 1985; 121 (4): 451PubMedCrossRef
27.
go back to reference McDougall IR. Graves’ disease: current concepts. Med Clin North Am 1991; 75: 79–95PubMed McDougall IR. Graves’ disease: current concepts. Med Clin North Am 1991; 75: 79–95PubMed
29.
go back to reference Solanki SV, Shah SS, Kothari UR. Thyroid acropachy. Indian J Med Sci 1973; 27: 708–710PubMed Solanki SV, Shah SS, Kothari UR. Thyroid acropachy. Indian J Med Sci 1973; 27: 708–710PubMed
30.
go back to reference Ross DS. Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease. Endocrinol Metab Clin North Am 2001; 30 (2): 245–264PubMedCrossRef Ross DS. Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease. Endocrinol Metab Clin North Am 2001; 30 (2): 245–264PubMedCrossRef
31.
go back to reference Ladenson PW. Diagnosis of thyrotoxicosis. In: Braverman LE, Utiger RD, editors. Werner and Ingbar’s the thyroid. 7th ed. Philadelphia: Lippincott-Raven, 1996: 708–712 Ladenson PW. Diagnosis of thyrotoxicosis. In: Braverman LE, Utiger RD, editors. Werner and Ingbar’s the thyroid. 7th ed. Philadelphia: Lippincott-Raven, 1996: 708–712
32.
go back to reference Kaplan MM, Meier DA, Dworkin HJ. Treatment of hyperthyroidism with radioac tive iodine. Endocrinol Metab Clin North Am 1998; 27 (1): 205–223PubMedCrossRef Kaplan MM, Meier DA, Dworkin HJ. Treatment of hyperthyroidism with radioac tive iodine. Endocrinol Metab Clin North Am 1998; 27 (1): 205–223PubMedCrossRef
33.
go back to reference Cooper DS. Antithyroid drugs for the treatment of hyperthyroidism caused by Graves’ disease. Endocrinol Metab Clin North Am 1998; 27 (1): 225–247PubMedCrossRef Cooper DS. Antithyroid drugs for the treatment of hyperthyroidism caused by Graves’ disease. Endocrinol Metab Clin North Am 1998; 27 (1): 225–247PubMedCrossRef
34.
go back to reference Ross DS. Syndromes of thyrotoxicosis with low radioactive iodine uptake. Endocrinol Metab Clin North Am 1998; 27 (1): 169–185PubMedCrossRef Ross DS. Syndromes of thyrotoxicosis with low radioactive iodine uptake. Endocrinol Metab Clin North Am 1998; 27 (1): 169–185PubMedCrossRef
35.
go back to reference Braverman LE, Utiger RD. Introduction to hypothyroidism. In: Braverman LE, Utiger RD, editors. Werner and Ingbar’s the thyroid. 7th ed. Philadelphia: Lippincott-Raven, 1996: 736–737 Braverman LE, Utiger RD. Introduction to hypothyroidism. In: Braverman LE, Utiger RD, editors. Werner and Ingbar’s the thyroid. 7th ed. Philadelphia: Lippincott-Raven, 1996: 736–737
36.
go back to reference Larsen PR, Davies TF, Hay ID. The thyroid gland. In: Wilson JD, Foster DW, Kronenberg HM, et al, editors. Williams textbook of endocrinology. 9th ed. Philadelphia: WB Saunders, 1998: 460–466 Larsen PR, Davies TF, Hay ID. The thyroid gland. In: Wilson JD, Foster DW, Kronenberg HM, et al, editors. Williams textbook of endocrinology. 9th ed. Philadelphia: WB Saunders, 1998: 460–466
37.
go back to reference Bernhard JD, Freedberg IM, Vogel LN. The skin in hypothyroidism. In: Braverman LE, Utiger RD, editors. Werner and Ingbar’s the thyroid. 7th ed. Philadelphia: Lippincott-Raven, 1996: 792–795 Bernhard JD, Freedberg IM, Vogel LN. The skin in hypothyroidism. In: Braverman LE, Utiger RD, editors. Werner and Ingbar’s the thyroid. 7th ed. Philadelphia: Lippincott-Raven, 1996: 792–795
39.
go back to reference Diven DG, Gwinup G, Newton RC. The thyroid. Dermatol Clin 1989; 7: 547–558PubMed Diven DG, Gwinup G, Newton RC. The thyroid. Dermatol Clin 1989; 7: 547–558PubMed
40.
go back to reference Al-Jubouri MA, Coombes EJ, Young RM, et al. Xanthoderma: an unusual presentation of hypothyroidism. J Clin Pathol 1994; 47 (9): 850–851PubMedCrossRef Al-Jubouri MA, Coombes EJ, Young RM, et al. Xanthoderma: an unusual presentation of hypothyroidism. J Clin Pathol 1994; 47 (9): 850–851PubMedCrossRef
42.
go back to reference Tosti A, Baran R, Dawber RPR. The nail in systemic diseases and drug-induced changes. In: Baran R, Dawber RPR, editors. Diseases of the nails and their management. 2nd ed. Oxford: Blackwell Scientific Publications, 1994: 175 Tosti A, Baran R, Dawber RPR. The nail in systemic diseases and drug-induced changes. In: Baran R, Dawber RPR, editors. Diseases of the nails and their management. 2nd ed. Oxford: Blackwell Scientific Publications, 1994: 175
43.
go back to reference Cunningham MJ, Zone JJ. Thyroid abnormalities in dermatitis herpetiformis: prevalence of clinical thyroid disease and thyroid autoantibodies. Ann Intern Med 1985; 102 (2): 194–196PubMed Cunningham MJ, Zone JJ. Thyroid abnormalities in dermatitis herpetiformis: prevalence of clinical thyroid disease and thyroid autoantibodies. Ann Intern Med 1985; 102 (2): 194–196PubMed
44.
go back to reference Stockigt JR. Free thyroid hormone:treasurement. Endocrinol Metab Clin North Am 2001; 30 (2): 265–289PubMedCrossRef Stockigt JR. Free thyroid hormone:treasurement. Endocrinol Metab Clin North Am 2001; 30 (2): 265–289PubMedCrossRef
45.
go back to reference Ladenson PW. Diagnosis of hypothyroidism. In: Braverman LE, Utiger RD, editors. Werner and Ingbar’s the thyroid. 7th ed. Philadelphia: LippincottRaven, 1996: 878–882 Ladenson PW. Diagnosis of hypothyroidism. In: Braverman LE, Utiger RD, editors. Werner and Ingbar’s the thyroid. 7th ed. Philadelphia: LippincottRaven, 1996: 878–882
46.
go back to reference Brent GA, Larsen PRo Treatment of hypothyroidism. In: Braverman LE, Utiger RD, editors. Werner and Ingbar’s the thyroid. 8th ed. Philadelphia: LippincottRaven, 2000: 853–858 Brent GA, Larsen PRo Treatment of hypothyroidism. In: Braverman LE, Utiger RD, editors. Werner and Ingbar’s the thyroid. 8th ed. Philadelphia: LippincottRaven, 2000: 853–858
47.
go back to reference Niepomniszcze H, Huaier AR. Skin disorders and thyroid diseases. J Endocrinol Invest 2001; 24: 628–638PubMed Niepomniszcze H, Huaier AR. Skin disorders and thyroid diseases. J Endocrinol Invest 2001; 24: 628–638PubMed
48.
go back to reference Lutfi RJ, Fridmanis M, Misiunas AL, et al. Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the melasma. J Clin Endocrinol Metab 1985; 61 (1): 28–31PubMedCrossRef Lutfi RJ, Fridmanis M, Misiunas AL, et al. Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the melasma. J Clin Endocrinol Metab 1985; 61 (1): 28–31PubMedCrossRef
49.
go back to reference Hegedus L, Heidenheim M, Gervil M, et al. High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol 1994; 74: 120–123PubMed Hegedus L, Heidenheim M, Gervil M, et al. High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol 1994; 74: 120–123PubMed
50.
51.
go back to reference Leznoff A, Sussman GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Anergy Clin Immunol 1989; 84 (1): 66–71CrossRef Leznoff A, Sussman GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Anergy Clin Immunol 1989; 84 (1): 66–71CrossRef
52.
go back to reference Rurnbyrt JS, Katz JL, Schocket AL. Resolution of chronic urticaria in patients with thyroid autoimmunity. J Anergy Clin Immunol 1995; 96 (6): 901–905CrossRef Rurnbyrt JS, Katz JL, Schocket AL. Resolution of chronic urticaria in patients with thyroid autoimmunity. J Anergy Clin Immunol 1995; 96 (6): 901–905CrossRef
53.
go back to reference Orgiazzi J. Anti-TSH receptor antibodies in clinical practice. Endocrinol Metab Clin North Am 2000; 29 (2): 339–355PubMedCrossRef Orgiazzi J. Anti-TSH receptor antibodies in clinical practice. Endocrinol Metab Clin North Am 2000; 29 (2): 339–355PubMedCrossRef
54.
go back to reference Findling JW, Aron DC, Tyrrell JB. Glucocrticoids and adrenal androgens. In: Greenspan FS, Strewler GJ, editors. Basic & clinical endocrinology. 5th ed. Connecticut: Appleton & Lange, 1997: 343–354 Findling JW, Aron DC, Tyrrell JB. Glucocrticoids and adrenal androgens. In: Greenspan FS, Strewler GJ, editors. Basic & clinical endocrinology. 5th ed. Connecticut: Appleton & Lange, 1997: 343–354
55.
go back to reference Findling JW, RaffH. Diagnosis and differential diagnosis of Cushing’s syndrome. Endocrinol Metab Clin North Am 2001; 30 (3): 729–747PubMedCrossRef Findling JW, RaffH. Diagnosis and differential diagnosis of Cushing’s syndrome. Endocrinol Metab Clin North Am 2001; 30 (3): 729–747PubMedCrossRef
56.
go back to reference Yanovski JA, Cutler GB. Glucocorticoid action and the clinical features of Cushing’s syndrome. Endocrinol Metab Clin North Am 1994; 23 (3): 487–509PubMed Yanovski JA, Cutler GB. Glucocorticoid action and the clinical features of Cushing’s syndrome. Endocrinol Metab Clin North Am 1994; 23 (3): 487–509PubMed
57.
go back to reference Panzer SW, Patrinely JR, Wilson HK. Exophthalmos and iatrogenic Cushing’s syndrome. Ophthal Plast Reconstr Surg 1994; 10 (4): 278–282PubMedCrossRef Panzer SW, Patrinely JR, Wilson HK. Exophthalmos and iatrogenic Cushing’s syndrome. Ophthal Plast Reconstr Surg 1994; 10 (4): 278–282PubMedCrossRef
58.
go back to reference Fisher B, Maibach HF. The effect of corticosteroids on human epidermal mitotic activity. Arch Dermatol 1971; 103: 39–43PubMedCrossRef Fisher B, Maibach HF. The effect of corticosteroids on human epidermal mitotic activity. Arch Dermatol 1971; 103: 39–43PubMedCrossRef
59.
go back to reference Rokowski K, Sheehy J, Cutroneo KR. Glucocorticoid-mediated selective reduction of functioning collagen messenger ribonucleic acid. Arch Biochem Biophys 1981; 210: 74–77PubMedCrossRef Rokowski K, Sheehy J, Cutroneo KR. Glucocorticoid-mediated selective reduction of functioning collagen messenger ribonucleic acid. Arch Biochem Biophys 1981; 210: 74–77PubMedCrossRef
60.
go back to reference Ferguson JK, Donald RA, Wetson TS, et al. Skin thickness in patients with acromegaly and Cushing’s syndrome and response to treatment. Clin Endocrinol 1983; 18 (4): 347–353CrossRef Ferguson JK, Donald RA, Wetson TS, et al. Skin thickness in patients with acromegaly and Cushing’s syndrome and response to treatment. Clin Endocrinol 1983; 18 (4): 347–353CrossRef
61.
go back to reference Orth DN, Kovacs WJ. The adrenal cortex. In: Wilson JD, Foster DW, Kronenberg HM, et al, editors. Williams textbook of endocrinology. 9th ed. Philadelphia: WB Saunders, 1998: 565–569 Orth DN, Kovacs WJ. The adrenal cortex. In: Wilson JD, Foster DW, Kronenberg HM, et al, editors. Williams textbook of endocrinology. 9th ed. Philadelphia: WB Saunders, 1998: 565–569
62.
go back to reference Matsuoka LY, Gavin JR, Goldman l Spectrum of endocrine abnormalities associated with acanthosis nigricans. Am J Med 1987; 83: 719–725PubMedCrossRef Matsuoka LY, Gavin JR, Goldman l Spectrum of endocrine abnormalities associated with acanthosis nigricans. Am J Med 1987; 83: 719–725PubMedCrossRef
63.
go back to reference Winkelmann RK, Scheen RS, Underhal LO. Acanthosis nigricans and endocrine disease. JAMA 1960; 174 (9): 1145–1152PubMedCrossRef Winkelmann RK, Scheen RS, Underhal LO. Acanthosis nigricans and endocrine disease. JAMA 1960; 174 (9): 1145–1152PubMedCrossRef
64.
go back to reference Findling JW, Raff H. Newer diagnostic techniques and problems in Cushing’s disease. Endocrinol Metab Clin North Am 1999; 28 (1): 191–210PubMedCrossRef Findling JW, Raff H. Newer diagnostic techniques and problems in Cushing’s disease. Endocrinol Metab Clin North Am 1999; 28 (1): 191–210PubMedCrossRef
65.
go back to reference Meier CA, Biller BMK. Clinical and biochemical evaluation of Cushing’s syndrome. Endocrinol Metab Clin North Am 1997; 26 (4): 741–762PubMedCrossRef Meier CA, Biller BMK. Clinical and biochemical evaluation of Cushing’s syndrome. Endocrinol Metab Clin North Am 1997; 26 (4): 741–762PubMedCrossRef
66.
67.
go back to reference Findling JW, Aron DC, TyrreH JB. Disorders of adrenocortical insufficiency. In: Greenspan FS, Strewler GJ, editors. Basic & clinical endocrinology. 5th ed. Connecticut: Appleton & Lange, 1997: 334–343 Findling JW, Aron DC, TyrreH JB. Disorders of adrenocortical insufficiency. In: Greenspan FS, Strewler GJ, editors. Basic & clinical endocrinology. 5th ed. Connecticut: Appleton & Lange, 1997: 334–343
68.
69.
go back to reference Barnett AH, Espiner EA, Donald RA. Patients presenting with Addison’s need not be pigmented. Postgrad Med J 1982; 58: 690–692PubMedCrossRef Barnett AH, Espiner EA, Donald RA. Patients presenting with Addison’s need not be pigmented. Postgrad Med J 1982; 58: 690–692PubMedCrossRef
70.
go back to reference Soffer LJ, Dorfman RI, Gabrilove JL. The human adrenal gland. Philadelphia: Lea and Febiger, 1961: 256–275 Soffer LJ, Dorfman RI, Gabrilove JL. The human adrenal gland. Philadelphia: Lea and Febiger, 1961: 256–275
71.
go back to reference Mountjoy KG. The human melanocyte stimulating hormone receptor has evolved to become “super-sensitive” to melanocortin peptides. Mol Cen Endocrinol 1994; 102 (1–2): R7–11CrossRef Mountjoy KG. The human melanocyte stimulating hormone receptor has evolved to become “super-sensitive” to melanocortin peptides. Mol Cen Endocrinol 1994; 102 (1–2): R7–11CrossRef
72.
go back to reference Hunt G, Todd C, Kyne S, et al. ACTH stimulates melanogenesis in cultured human melanocytes. J Endocrinol 1994; 140 (1): R1–R3PubMedCrossRef Hunt G, Todd C, Kyne S, et al. ACTH stimulates melanogenesis in cultured human melanocytes. J Endocrinol 1994; 140 (1): R1–R3PubMedCrossRef
73.
go back to reference Parker LN. Addison’s disease and Cushing’s syndrome. In: Parker LN, editor. Adrenal androgens in clinical medicine. San Diego: Academic Press, 1989: 158–174 Parker LN. Addison’s disease and Cushing’s syndrome. In: Parker LN, editor. Adrenal androgens in clinical medicine. San Diego: Academic Press, 1989: 158–174
74.
go back to reference Zelissen PMJ, Bast EJEG, Croughs RJM. Associated autoimmunity in Addison’s disease. J Autoimmun 1995; 8: 121–130PubMedCrossRef Zelissen PMJ, Bast EJEG, Croughs RJM. Associated autoimmunity in Addison’s disease. J Autoimmun 1995; 8: 121–130PubMedCrossRef
75.
go back to reference Grinspoon SK, Biller BM. Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 1994; 79: 923–931PubMedCrossRef Grinspoon SK, Biller BM. Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 1994; 79: 923–931PubMedCrossRef
76.
go back to reference Malchoff CD, Carey RM. Adrenal insufficiency. In: Bardin CW, editor. Current therapy in endocrinology and metabolism. 6th ed. St Louis: Mosby-Year Book Inc, 1997: 142–146 Malchoff CD, Carey RM. Adrenal insufficiency. In: Bardin CW, editor. Current therapy in endocrinology and metabolism. 6th ed. St Louis: Mosby-Year Book Inc, 1997: 142–146
77.
go back to reference Thorner MO, Vance ML, Laws ER, et al. The anterior pituitary. In: Wilson JD, Foster DW, Kronenberg HM, et al, editors. Williams textbook of endocrinology. 9th ed. Philadelphia: WB Saunders, 1998: 295–307 Thorner MO, Vance ML, Laws ER, et al. The anterior pituitary. In: Wilson JD, Foster DW, Kronenberg HM, et al, editors. Williams textbook of endocrinology. 9th ed. Philadelphia: WB Saunders, 1998: 295–307
78.
go back to reference Melmed S. Clinical manifestations of acromegaly. UpToDate 1998; 6 (1): 1–5 Melmed S. Clinical manifestations of acromegaly. UpToDate 1998; 6 (1): 1–5
79.
go back to reference Davidoff LM. Studies in acromegaly: III. the anamnesis ans symptomatology in one hundred cases. Endocrinology 1926; 10: 461–483CrossRef Davidoff LM. Studies in acromegaly: III. the anamnesis ans symptomatology in one hundred cases. Endocrinology 1926; 10: 461–483CrossRef
80.
81.
go back to reference Melmed S. Diagnosis of acromegaly. UpToDate 1997; 6 (1): 1–4 Melmed S. Diagnosis of acromegaly. UpToDate 1997; 6 (1): 1–4
83.
go back to reference Carr BR. Disorders of the ovaries and female reproductive tract. In: Wilson JD, Foster DW, Kronenberg HM, et al, editors. Williams textbook of endocrinology. 9th ed. Philadelphia: WB Saunders, 1998: 795–799 Carr BR. Disorders of the ovaries and female reproductive tract. In: Wilson JD, Foster DW, Kronenberg HM, et al, editors. Williams textbook of endocrinology. 9th ed. Philadelphia: WB Saunders, 1998: 795–799
84.
go back to reference Taylor AE. Polycystic ovary syndrome. Endocrinol Metab Clin North Am 1008; 27 (4): 877–902CrossRef Taylor AE. Polycystic ovary syndrome. Endocrinol Metab Clin North Am 1008; 27 (4): 877–902CrossRef
87.
go back to reference Dagher HN, Aboujaoude ZC, Jabbour SA. Chronic urticaria: an unusual initial manifestation of primary hyperparathyroidism. Endocr Pract 2002; 8 (1): 47–49PubMed Dagher HN, Aboujaoude ZC, Jabbour SA. Chronic urticaria: an unusual initial manifestation of primary hyperparathyroidism. Endocr Pract 2002; 8 (1): 47–49PubMed
88.
go back to reference Goltzman D. Hypoparathyroidism. In: Favus MJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 3rd ed. Philadelphia: Lippincott-Raven, 1996: 220–223 Goltzman D. Hypoparathyroidism. In: Favus MJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 3rd ed. Philadelphia: Lippincott-Raven, 1996: 220–223
89.
go back to reference Strewler GJ. Mineral metabolism & metabolic bone disease. In: Greenspan FS, Strewler GJ, editors. Basic & clinical endocrinology. 5th edn. Connecticut: Appleton & Lange, 1997: 288–289 Strewler GJ. Mineral metabolism & metabolic bone disease. In: Greenspan FS, Strewler GJ, editors. Basic & clinical endocrinology. 5th edn. Connecticut: Appleton & Lange, 1997: 288–289
90.
go back to reference Sutphin A, Fuller A, McCune DJ. Five cases (three in siblings) of idiopathic hypoparathyroidism associated with moniliasis. J Clin Endocrinol 1943; 3: 625–634CrossRef Sutphin A, Fuller A, McCune DJ. Five cases (three in siblings) of idiopathic hypoparathyroidism associated with moniliasis. J Clin Endocrinol 1943; 3: 625–634CrossRef
91.
go back to reference Bilezikian JP. Primary hyperparathyroidism: when to observe and when to operate. Endocrinol Metab Clin North Am 2000; 29 (3): 465–478PubMedCrossRef Bilezikian JP. Primary hyperparathyroidism: when to observe and when to operate. Endocrinol Metab Clin North Am 2000; 29 (3): 465–478PubMedCrossRef
92.
go back to reference American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1998; 21 (S1): S5–S19 American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1998; 21 (S1): S5–S19
93.
go back to reference Muner SA, Winkelman RK. Necrobiosis lipoidica diabeticorum, a clinical and pathological investigation of 171 cases. Arch Dermatol 1966; 93 (3): 272–281CrossRef Muner SA, Winkelman RK. Necrobiosis lipoidica diabeticorum, a clinical and pathological investigation of 171 cases. Arch Dermatol 1966; 93 (3): 272–281CrossRef
94.
go back to reference Cruz PD, Hud JA. Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans. J Invest Dermatol 1992; 98 (6 Suppl.): 82S–85SCrossRef Cruz PD, Hud JA. Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans. J Invest Dermatol 1992; 98 (6 Suppl.): 82S–85SCrossRef
95.
96.
go back to reference Macaron C, Winter RJ, Traisman HS, et al. Vitiligo and juvenile diabetes mellitus. Arch Dermatol 1977; 113 (11): 1515–1517PubMedCrossRef Macaron C, Winter RJ, Traisman HS, et al. Vitiligo and juvenile diabetes mellitus. Arch Dermatol 1977; 113 (11): 1515–1517PubMedCrossRef
98.
go back to reference Stawiski MA, Voorhees JJ. Cutaneous signs of diabetes mellitus. Cutis 1976; 18 (3): 415–421PubMed Stawiski MA, Voorhees JJ. Cutaneous signs of diabetes mellitus. Cutis 1976; 18 (3): 415–421PubMed
99.
go back to reference Fleischmajor R, Lara N. Scleredema adultorum: a histochenical and biochemical study. Arch Dermatol 1965; 92: 643–652CrossRef Fleischmajor R, Lara N. Scleredema adultorum: a histochenical and biochemical study. Arch Dermatol 1965; 92: 643–652CrossRef
100.
go back to reference Cohen BA, Wheeler CE, Briggman RA. Scleredema of Buschke and diabetes mellitus. Arch Dermatol 1970; 101: 27–35CrossRef Cohen BA, Wheeler CE, Briggman RA. Scleredema of Buschke and diabetes mellitus. Arch Dermatol 1970; 101: 27–35CrossRef
101.
go back to reference Clark CV, Pentland B, Ewing DJ, et al. Decreased skin wrinkling in diabetes mellitus. Diabetes Care 1984; 7 (3): 224–227PubMedCrossRef Clark CV, Pentland B, Ewing DJ, et al. Decreased skin wrinkling in diabetes mellitus. Diabetes Care 1984; 7 (3): 224–227PubMedCrossRef
102.
go back to reference Lithner F. Lesions of the legs in diabetics and in patients with familial amyloidosis and polyneuropathy. Acta Med Scand Suppl 1976; 589: 1–23PubMed Lithner F. Lesions of the legs in diabetics and in patients with familial amyloidosis and polyneuropathy. Acta Med Scand Suppl 1976; 589: 1–23PubMed
103.
go back to reference McCulloch DK. Basic insulin regimens in diabetes mellitus. UpToDate 2003; 11 (1): 1–6 McCulloch DK. Basic insulin regimens in diabetes mellitus. UpToDate 2003; 11 (1): 1–6
104.
go back to reference Jabbour SA, Goldstein BJ. Improving disease management with new treatments for type 2 diabetes mellitus. Clin Geriatr 2001; 9 (5): 157–168 Jabbour SA, Goldstein BJ. Improving disease management with new treatments for type 2 diabetes mellitus. Clin Geriatr 2001; 9 (5): 157–168
Metadata
Title
Cutaneous Manifestations of Endocrine Disorders
A Guide for Dermatologists
Author
Dr Serge A. Jabbour
Publication date
01-05-2003
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 5/2003
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200304050-00003

Other articles of this Issue 5/2003

American Journal of Clinical Dermatology 5/2003 Go to the issue

Leading Article

Chronic Urticaria